证券研究报告：医药生物 | 公司点评报告 发布时间：2025-07-31 股票投资评级 买入 |上调 个股表现 2024-07 2024-10 2024-12 2025-03 2025-05 2025-07 -12% -2% 8% 18% 28% 38% 48% 58% 68% 78% 华康洁净 医药生物 资料来源：聚源，中邮证券研究所 公司基本情况 | 最新收盘价（元） | 33.19 | | --- | --- | | 总股本/流通股本（亿股）1.06 | / 0.71 | | 总市值/流通市值（亿元）35 | / 23 | | 52 周内最高/最低价 | 33.19 / 15.69 | | 资产负债率(%) | 57.3% | | 市盈率 | 52.68 | | 第一大股东 | 谭平涛 | 研究所 分析师:盛丽华 SAC 登记编号:S1340525060001 Email:shenglihua@cnpsec.com l 盈利预测与估值 预测 2025-2027 年 EPS 值分别为 1.52/2.18/3.14 元/股，现价对 应 PE 分别为 21.85/15.23/10.56 倍。给予"买入"评级。 ...

Core Viewpoint - Huakang Clean (301235) has been awarded the bid for the "Tianjin Third Central Hospital (Dongli District) New Site Expansion Project Operating Room and Purification Engineering First Bid Section" with a bid price of 64.425 million yuan, which accounts for 3.77% of the company's audited revenue for 2024 [1] Summary by Relevant Categories Project Details - The project is expected to commence on May 25, 2025, and conclude by December 30, 2025 [1] - The engineering quality must meet national acceptance standards [1] Financial Impact - The project is anticipated to have a positive impact on the company's net profit in future years [1]

华康洁净（301235）公告，公司收到中标通知书，与中元建设集团组成的联合体中标"嘉兴市第二医院 整体迁建项目净化及实验室工程"，中标金额为1.67亿元。公司预计份额为1.33亿元，占公司2024年度经 审计营业收入的7.81%。项目总建筑面积46.13万平方米，最高洁净等级为百级，工期为260个日历天。 ...

Summary of Key Points from Conference Call Industry Overview - The conference call primarily discusses the bond market and its dynamics, focusing on the recent fluctuations and the outlook for 2025 [2][4][5]. Core Insights and Arguments - **Market Volatility**: The bond market experienced significant volatility in recent weeks, with major adjustments observed on Mondays followed by some stabilization, but pressure returned by Friday. The risks identified include tightening liquidity, rising interbank certificate of deposit (CD) rates, and adjustments in market expectations regarding liquidity [2][4]. - **Liquidity Conditions**: There are signs of marginal easing in liquidity, with stable overnight repo rates and good issuance of interbank CDs. The central bank has maintained a cautious stance on long-term interest rate changes, indicating potential for further easing if economic pressures increase [4][7]. - **2025 Market Outlook**: The expectation for a one-sided bull market in bonds for 2025 has weakened, with a likely shift to a range-bound market characterized by significant volatility. Long-duration assets are seen as less secure, while short-duration credit strategies and CDs may offer better advantages [5][6]. - **Economic Indicators**: Recent macroeconomic data shows a decline in industrial production, but high operating rates in the consumption chain and improved real estate market conditions. Consumer demand, particularly in automotive sales, remains strong despite price pressures [6][8]. - **Central Bank Policies**: The central bank emphasizes the coordination of monetary and fiscal policies, indicating a response to economic pressures. Recent actions include net liquidity injections to support the market, with a focus on maintaining stable funding rates [8][10]. Additional Important Content - **Company-Specific Insights**: - **Huakang Medical**: The company, now rebranded as "Huakang Shortcut," focuses on cleanroom engineering with an order backlog of nearly 3 billion yuan and anticipates a 10% growth in its medical segment. The company is expanding into laboratory and electronic cleanroom businesses, which have shorter project cycles and quicker payment terms [2][13][14]. - **Jintian Co., Ltd.**: The company is closely monitoring its convertible bonds and ensuring repayment capabilities. It expects improved processing fees in 2024 and good production schedules in 2025, focusing on net profit margin improvements and high-quality order acquisition [2][15]. - **Market Behavior**: Banks have been major sellers in the bond market, while funds and brokerages have shifted to significant net buying. The leverage ratios of various financial institutions have shown mixed trends, indicating a recovery in market sentiment [16]. Conclusion - The bond market is currently navigating through a complex landscape of liquidity adjustments, economic pressures, and evolving investor sentiment. Companies like Huakang Medical and Jintian Co., Ltd. are positioned to leverage their respective market segments amidst these changes, while the central bank's policies will play a crucial role in shaping future market conditions [2][4][5][13][15].